PHIBRO ANIMAL HEALTH CORP - COMMON-STOCK (PAHC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2025

Type / Class
Equity / COMMON-STOCK
Symbol
PAHC on Nasdaq
Shares outstanding
20,448,784
Price per share
$41.08
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
19,319,071
Total reported value
$722,004,901
% of total 13F portfolios
0%
Share change
-253,843
Value change
-$10,913,077
Number of holders
224
Price from insider filings
$41.08
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PHIBRO ANIMAL HEALTH CORP - COMMON-STOCK (PAHC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BFI Co., LLC 49% -1.2% $906,610,607 -$10,211,942 20,000,234 -1.1% BFI Co., LLC 11 Dec 2025
BlackRock, Inc. 16% $57,576,134 3,195,124 BlackRock, Inc. 31 Mar 2025
BARCLAYS PLC 5.1% $41,121,074 1,042,888 Barclays PLC 31 Dec 2025
PZENA INVESTMENT MANAGEMENT LLC 3.6% -51% $13,043,417 -$13,280,199 723,830 -50% PZENA INVESTMENT MANAGEMENT LLC 31 Mar 2025
BRANDES INVESTMENT PARTNERS, LP 3.3% $11,942,719 662,748 Brandes Investment Partners, L.P. 31 Dec 2024

As of 31 Dec 2025, 224 institutional investors reported holding 19,319,071 shares of PHIBRO ANIMAL HEALTH CORP - COMMON-STOCK (PAHC). This represents 94% of the company’s total 20,448,784 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PHIBRO ANIMAL HEALTH CORP - COMMON-STOCK (PAHC) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 3,345,487 -2.4% 0% $124,987,396
VANGUARD GROUP INC 7.5% 1,539,593 +0.91% 0% $57,519,196
STATE STREET CORP 4.6% 942,279 +5.4% 0% $35,203,543
ACADIAN ASSET MANAGEMENT LLC 3.4% 702,648 -11% 0.04% $26,240,000
FMR LLC 3.4% 688,616 +15% 0% $25,726,676
MILLENNIUM MANAGEMENT LLC 3.1% 641,313 +4227% 0.02% $23,959,454
GEODE CAPITAL MANAGEMENT, LLC 2.8% 569,111 +4% 0% $21,265,072
RENAISSANCE TECHNOLOGIES LLC 2.7% 545,300 -1.8% 0.03% $20,372,408
DIMENSIONAL FUND ADVISORS LP 2.4% 492,335 +1.4% 0% $18,393,742
MORGAN STANLEY 2.2% 447,312 +2.6% 0% $16,711,612
Nuveen, LLC 2.2% 444,268 -7.3% 0% $16,597,852
Dana Investment Advisors, Inc. 1.6% 328,676 -7.4% 0.36% $12,279,335
Qube Research & Technologies Ltd 1.4% 291,773 +14% 0.02% $10,900,639
Ranger Investment Management, L.P. 1.4% 279,425 -6.8% 0.72% $10,439,318
JPMORGAN CHASE & CO 1.3% 271,517 +14% 0% $10,143,875
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 268,652 -0.93% 0% $10,036,844
Invesco Ltd. 1.3% 258,257 -20% 0% $9,648,481
CastleKnight Management LP 1.2% 240,897 -40% 0.51% $8,999,912
Bank of New York Mellon Corp 1.1% 232,183 -13% 0% $8,674,357
GLOBEFLEX CAPITAL L P 1.1% 215,257 -7% 1.2% $8,042,002
NORTHERN TRUST CORP 1% 213,295 -3.9% 0% $7,968,700
OBERWEIS ASSET MANAGEMENT INC/ 1% 209,800 0.29% $7,838,128
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.99% 201,729 -33% 0% $7,536,595
CRAWFORD INVESTMENT COUNSEL INC 0.97% 198,386 -8.8% 0.12% $7,411,701
Capricorn Fund Managers Ltd 0.9% 184,101 -27% 1.7% $6,878,013

Institutional Holders of PHIBRO ANIMAL HEALTH CORP - COMMON-STOCK (PAHC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 19,319,071 $722,004,901 -$10,913,077 $37.36 224
2025 Q3 19,599,542 $792,990,493 -$23,249,781 $40.46 216
2025 Q2 20,349,724 $519,721,694 +$4,932,349 $25.54 192
2025 Q1 20,230,331 $431,882,531 -$6,976,163 $21.36 181
2024 Q4 20,760,076 $435,958,146 +$5,855,068 $21.00 171
2024 Q3 20,262,212 $456,562,597 +$4,978,935 $22.52 145
2024 Q2 20,104,261 $337,332,099 -$3,613,178 $16.77 138
2024 Q1 20,390,841 $263,815,154 +$4,780,079 $12.93 137
2023 Q4 20,498,053 $237,357,830 +$2,393,108 $11.58 134
2023 Q3 20,056,787 $257,066,743 +$637,840 $12.77 124
2023 Q2 19,973,690 $273,662,577 -$4,846,655 $13.70 127
2023 Q1 20,301,393 $311,012,290 +$5,422,420 $15.32 132
2022 Q4 19,989,777 $268,089,718 +$1,271,732 $13.41 129
2022 Q3 19,929,636 $264,908,464 -$16,816,591 $13.29 138
2022 Q2 20,667,086 $395,381,581 +$3,633,408 $19.13 139
2022 Q1 20,531,472 $408,823,760 +$4,262,047 $19.95 143
2021 Q4 20,288,359 $413,858,025 -$6,010,185 $20.42 133
2021 Q3 20,413,494 $439,740,209 -$19,573,080 $21.54 130
2021 Q2 21,302,215 $615,117,148 +$14,536,483 $28.88 142
2021 Q1 21,042,222 $513,508,005 +$22,206,837 $24.40 137
2020 Q4 20,306,618 $394,390,866 -$4,768,468 $19.42 129
2020 Q3 20,646,036 $359,251,334 -$10,719,506 $17.40 131
2020 Q2 44,667,289 $1,140,259,090 +$598,684,081 $26.27 148
2020 Q1 20,463,242 $494,535,691 -$12,127,558 $24.17 148
2019 Q4 20,557,292 $510,464,148 +$14,222,033 $24.83 148
2019 Q3 20,621,951 $440,106,105 -$15,741,828 $21.33 147
2019 Q2 21,057,891 $668,876,686 +$39,304,468 $31.77 164
2019 Q1 20,438,371 $674,469,078 +$6,675,566 $33.00 173
2018 Q4 20,247,477 $651,077,628 +$2,126,967 $32.16 187
2018 Q3 20,133,697 $863,784,342 +$21,235,963 $42.90 188
2018 Q2 19,602,864 $902,263,512 +$26,896,969 $46.05 170
2018 Q1 19,555,491 $776,428,353 +$30,646,488 $39.70 167
2017 Q4 19,277,485 $646,026,747 -$9,662,597 $33.50 166
2017 Q3 19,413,132 $719,096,867 +$10,843,119 $37.05 160
2017 Q2 19,118,590 $707,142,729 +$31,448,680 $37.05 165
2017 Q1 18,613,735 $523,086,692 +$94,557,319 $28.10 151
2016 Q4 18,454,313 $541,292,006 -$4,782,470 $29.30 139
2016 Q3 18,623,231 $506,139,803 +$7,597,360 $27.18 119
2016 Q2 18,864,791 $352,709,535 -$18,147,622 $18.66 120
2016 Q1 19,230,618 $520,246,100 -$23,256,316 $27.04 120
2015 Q4 20,005,841 $602,775,758 +$44,273,288 $30.13 120
2015 Q3 18,566,690 $587,300,237 +$44,210,194 $31.63 121
2015 Q2 17,185,940 $669,156,762 -$1,896,768 $38.94 119
2015 Q1 17,343,808 $613,840,303 +$318,429 $35.41 107
2014 Q4 17,598,205 $554,999,626 +$4,023,253 $31.55 90
2014 Q3 17,459,966 $391,274,678 +$65,706,329 $22.41 68
2014 Q2 14,541,709 $319,188,457 +$319,161,458 $21.95 64